Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Morphic Medical logo — Innovative therapies for type 2 diabetes and obesity, rooted...

Morphic Medical

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.

Founded 2003 United States Boston, United States 50 employees Post-IPO Equity Total: $200.35M Biotechnology, Health Care +2

General Information

Company Name Morphic Medical
Founded Year 2003
Location United States Boston, United States
Employees 50
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Morphic Medical. To contact Morphic Medical, visit morphicmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Morphic Medical compare?

A PDF of Morphic Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Morphic Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Morphic Medical

Morphic Medical, formerly known as GI Dynamics Inc., is a pioneer in developing innovative therapies for type 2 diabetes and obesity. The company's flagship product, RESET® (EndoBarrier), is an endoscopically delivered device therapy that provides a non-surgical alternative for treating type 2 diabetes and obesity. It is important to note that RESET is currently limited to investigational use only and is not approved for sale in the United States. Founded in 2003, Morphic Medical is based in Boston, Massachusetts, and operates within the Biotechnology, Health Care, Health and Wellness, and Medical Devices sectors. In August 2019, the company secured a significant $10.00M Post-IPO Equity investment from Crystal Amber. The focus on non-surgical therapies for type 2 diabetes and obesity positions Morphic Medical as an emerging player in the healthcare innovation space, with potential for impactful growth and value creation.

Business keywords: Medical Device, Endoscopic Therapy, Type 2 Diabetes Treatment, Obesity Treatment, Metabolic Diseases Therapy, Non-Surgical Treatment, Device Therapy, EndoBarrier, Innovative Therapies, Medical Innovation, Clinical Research, Non-Surgical Alternative, Medical Device Development, Medical Research

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $10.00M 1
Crystal Amber
23 Aug 2019
Post IPO Equity $5.00M -
20 Sep 2018
Post IPO Equity $1.80M -
08 May 2018
Post IPO Equity $2.05M -
22 Jan 2018
Post IPO Debt $5.00M -
15 Jun 2017
Post IPO Equity $1.10M -
14 Dec 2016
Post IPO Equity $34.30M -
06 May 2014
Post IPO Equity $57.50M -
03 Jul 2013
Post IPO Equity $37.50M -
15 Sep 2011
Venture Round $15.00M 1
Medtronic
07 Jan 2010

View All 13 Funding Rounds

Morphic Medical Alternatives & Competitors

View All Alternatives
Morphic Medical vs
Metamodix
Metamodix

Metamodix is dedicated to reducing the human and financial costs of Type 2 Diabetes. We have develop...

Venture round
3 employees
Health Care, Life Sciences
Compare Morphic Medical vs Metamodix
Morphic Medical vs
Tongee Medical Technology
Tongee Medical Technology

Pioneering advanced medical solutions for metabolic diseases including obesity, type 2 diabetes, and...

Series B
Biotechnology, Health Care
Compare Morphic Medical vs Tongee Medical Technology
Morphic Medical vs
Fractyl Health
Fractyl Health United States

Dedicated to novel therapies that can sustain long term weight management.

Series F
104 employees
Biotechnology, Health Care
Also compare with: Morphic Medical vs Aspire Bariatrics Aspire Bariatrics View all alternatives

FAQ About Morphic Medical

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.
Morphic Medical was founded in 2003.
Morphic Medical is headquartered in Boston, United States.
Morphic Medical operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on Medical Device, Endoscopic Therapy, Type 2 Diabetes Treatment and Obesity Treatment.
Morphic Medical has approximately 50 employees.
Morphic Medical has completed 13 funding rounds, raising a total of $200.35M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Morphic Medical include Metamodix, Tongee Medical Technology, Fractyl Health, Endogenex, DiObex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Morphic Medical and Metamodix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Morphic Medical, https://bouncewatch.com/company/gi-dynamics, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes